-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PD-1 Silent PSMA Or PSCA Targeted CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PD-1 Silent PSMA Or PSCA Targeted CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PD-1 Silent PSMA...
-
Product Insights
NewLikelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...
-
Analyst Opinions
NewCocktail Culture – Industry Insights, Consumer Drivers, Brand Challenges and Innovation Landscape
Cocktail Culture Industry Report Overview The cocktail culture is a historic trend that has undergone several movements over the decades. In the 21st century, it has benefited from the craft alcohol movement and demand for premium experiences.  In 2024, cocktail culture has been influenced by relatively recent developments such as the craft craze, COVID's elevation of home-based indulgence and entertaining, increased RTD product diversity and sophistication, and the emergence of a more experiential-focused Gen Z consumer base. The ‘Cocktail Culture...
-
Sector Analysis
Secondhand Selling – Shopping Trends and Consumer Insights, 2024
Secondhand Selling Market Overview The secondhand market is constrained by concerns about the quality of secondhand goods, particularly, from consumers in Spain, Italy, and China. However, cost is one of the factors driving secondhand clothing & footwear buying, with more than 60% of consumers globally excluding China. China is majorly focusing on getting access to vintage, limited-edition, or unique items including all the other countries. Owing to this, Chinese consumers prefer items secondhand as they are more affordable. Buy the...
-
Analyst Opinions
Beyond Filters – A Deep Dive into the Health and Beauty Choices of Generation Z and Generation Alpha
Health and Beauty Choices of Generation Z and Generation Alpha Report Overview Gen Z has been exposed to the COVID-19 pandemic and the cost-of-living crisis during their formative years. They have also experienced more ethnic diversity growing up, and considerably higher rates of education compared to their previous generations. Due to such factors, they are less loyal to brands compared to boomers and the Silent Generation. Around half of them intend to cut back on health and beauty products to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Mantle Cell Lymphoma Drug Details: Ensomafusp alfa...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Follicular Lymphoma Drug Details: Ensomafusp alfa (RG-6076, RO-7227166)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Marginal Zone B-cell Lymphoma Drug Details:...